Ex-BMS exec wins Aussie Country Lead role
After more than 15 years at BMS, this well-known executive has joined a Canadian company to lead its Australian operations
After more than 15 years at BMS, this well-known executive has joined a Canadian company to lead its Australian operations
Shareholders turned up the heat at the company's AGM this morning, with the outgoing Chair conceding it had overpaid for an US$11.7B acquisition
The bright future pharma has been dreaming of has arrived... at least for some with positive sentiment on a steep climb - except when it comes to the prospect of finding a new job
A company navigating Australia's reimbursement system for the first time is kicking off the race for Government funding
Long-time boss to be replaced next year by someone whose history with the organisation runs just as deep
National Sales Manager Sharyn Junkeer shares the lessons she's painfully learned about life and career after suffering critical injuries in a horror bus crash
Health Minister has not upped his security in the last week, but concedes changes likely need to be made
Departures from companies, Australia and even industry have dominated the latest round of job moves across pharma
A new form of a gene therapy expands the indicated population to catch those who weren't diagnosed in time
Temperatures were high when three Sydney MPs visited the pharma's Macquarie Park office. Find out why
Over a tumultuous few hours, impressive data on the world's first mRNA cancer vaccine was leaked, then praised, before a tumble on the stock market
Inducted into the Hall of Fame as a "pioneer of breaking glass ceilings" in both gender and age, this pharma leader has been honoured for her vision and courage
Healthtech has emerged as a major force in this year’s LinkedIn Top Startups Australia list, an annual ranking of the emerging companies where professionals want to work
UQ researchers selected to help the US produce personalised genetic therapies in hospitals to deliver RNA medicines to patients within days of diagnosis, instead of months
Funding CAR T treatments isn't enough when structural barriers prevent the majority of referrals from accessing CAR T.
Agreement brings together innovative anti-infective development platform and the Aussie giant's established regulatory, market access and commercial capabilities
This well-known boss is back in Australia and leading the region for a company that's chasing approvals globally for a drug that's been hailed a game-changer
An industry survey has uncovered the most important motivator for workplace engagement with more than 2300 open-ended comments pointing to one must-have
World-class facility in Melbourne will help deliver the next generation of life-changing treatments in cancer, heart disease, and neurological and autoinflammatory diseases
A lawsuit has been filed by investors who bought shares during a calamitous price plunge but CSL has promised to 'vigorously' defend all accusations
After a global search, CSL has picked a former Aussie GM and a 'world-class, purpose-driven' high-flyer from a rival pharma to be its fourth CEO
An Australian company is helping time-poor doctors stay up to speed with the latest research by turning clinical papers into podcasts with pharmas on board as sponsors
Three flagship events brought together by AusBiotech for the first time is underway on the Gold Coast with more than 2500 expected to attend
DHL has introduced advanced automation as part of a $9 million upgrade of its pharma facility in South-West Sydney
New website reveals that Australian patients are among the most active in the world when it comes to taking their case for medicines access to drug-pricing regulators
The more free meals a doctor receives from pharma, the more likely they are to prescribe less appropriate or more expensive drugs, according to a new review
This ASX-listed company has increased its stake to own two-thirds of a joint venture started two years ago but investors are not impressed